XML 58 R33.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
SCHEDULE OF FAIR VALUE OF OPTIONS GRANTED USING THE BLACK-SCHOLES OPTION PRICING MODEL

 

   As of December 31, 
   2023   2022 
Exercise price   $0.8-$0.14    $0.28-$0.65 
Expected volatility   95%-90%    93%-95% 
Risk-free interest   4.5%-3.8%    1.5%-4.5% 
Expected life of up to (years)   4.1-4.4    3.5-4.5 

 

SCHEDULE OF OPTION ACTIVITY

The following table summarizes the option activity for the years ended December 31, 2023, and 2022 for options granted to employees, officers, and directors:

 

   As of December 31,  
   2023   2022  2021
   Number of options   Weighted average exercise price  

Weighted average remaining contractual term.

(In years)

   Number of options   Weighted average exercise price  

Weighted average remaining contractual term.

(In years)

  Number of options    

Weighted average exercise price

   

Weighted average remaining contractual term.

(In years)

 
Outstanding at beginning of period   34,253,216   $0.43    5.92    22,860,713   $0.5    4.84    24,076,750     $ 0.47       1.61  
Granted   2,675,000              13,075,000              3,355,000                  
Exercised   -              (33,333)             (2,707,286 )                
Forfeited   (1,308,333)             (1,649,164)             (1,863,751 )                
Outstanding at the end of period   35,619,883   $0.13    4.13    34,253,216   $0.43    5.92    22,860,713       0.5       4.84  
Exercisable at the end of period   23,525,726              19,427,796              14,749,296                  

 

(*) The weighted average fair value of options granted during the year ended December 31, 2023, was $ 0.04 per share.

SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE

The total share-based compensation expense, related to Ordinary Shares, options granted to employees, directors and service providers was comprised, at each period, as follows:



   2023   2022   2021 
  

Year ended

December 31,

 
   2023   2022   2021 
   USD in thousands 
Cost of revenues   9    25    5 
Research and development   849    929    1,161 
Sales and Marketing   118    196    169 
General and administrative   465    676    1,129 
Share-based compensation expense    1,441    1,826    2,464 
Less: Share-based compensation expense attributable to non-controlling interests   150    225    154 
Share-based compensation expense attributable to Foresight Autonomous Holdings Ltd.   1,291    1,601    2,310